Taller, stronger, sharper: Desi pharma is on a roll

India has witnessed a significant growth in pharmaceutical generic brands with sales over ₹100 crore in the last 15 years. These brands now make up 44% of the domestic formulation market valued at around ₹2 lakh crore. A report by investment banking firm Avendus Capital highlights the exponential increase in brands with sales exceeding ₹100 crore, reaching 388 in FY24 from 21 in FY09. These brands, including some with sales above ₹500 crore, have outpaced the industry growth rate, attributed to factors like lifestyle diseases and quality issues driving reliance on trusted brands.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/z5r9btV
via IFTTT